Merck KGaA (OTCMKTS:MKGAF – Get Free Report) was down 4.8% during trading on Monday . The company traded as low as $122.3570 and last traded at $122.3930. Approximately 901 shares traded hands during trading, an increase of 61% from the average daily volume of 558 shares. The stock had previously closed at $128.5830.
Merck KGaA Stock Performance
The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The firm’s 50 day moving average is $148.19 and its 200-day moving average is $139.76. The stock has a market capitalization of $16.09 billion, a price-to-earnings ratio of 19.01 and a beta of 0.96.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- I tried out Elon Musk’s new AI tech — it floored me
- Iran isn’t the real war
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
